RxDoctor Payments Data

Caryn Stoller

Child & Adolescent Psychiatry · Knoxville, TNNPI 1023215423

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations.

$2,497in general payments, 2019–2025

Across 140 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$540
  • Sunovion Pharmaceuticals Inc.$419
  • Neurocrine Biosciences, Inc.$271
  • Takeda Pharmaceuticals U.S.A., Inc.$173
  • Supernus Pharmaceuticals, Inc.$171
  • Otsuka America Pharmaceutical, Inc.$147
  • plus $777 from 15 others

What the payments were for

  • Food & beverage$2,497100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,497 in reported general payments places this provider in the 85th percentile of 43 child & adolescent psychiatry providers in Tennessee.

See all child & adolescent psychiatry providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole11$15,219
Lamotrigine16$1,702
Gabapentin14$167

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$147$15,21911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 43 child & adolescent psychiatry providers in Tennessee.

Other child & adolescent psychiatry in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →